WSW, NY, August 25th, 2026, FinanceWireModerna's cancer news sent its stock up 177% in a single day (NASDAQ: MRNA), from ...
Hosted on MSN
Moderna and Merck shares soar on mRNA cancer vaccine
Moderna and Merck shares soared on Wednesday after the companies said a personalized mRNA treatment hit its target of preventing skin cancer from recurring or spreading in a late-stage clinical trial.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results